Study found DNA-based screen was more than 90 percent accurate in predicting recurrence
by Malm1313 on Thu Dec 18, 2008 12:00 AM
Whats the latest on intermittent lupron injections? My husband (53) has had prostectomy, radiation, Tomotherapy and now on Lupron for 1 1/2 yrs. Mets to peri-aortic lymphs. PSA .01 since lupron began. Considering intermittent, but need more input.
by Thoosier on Fri Dec 19, 2008 12:00 AM
Man of Lori:
That is a very good response to Lupron, and intermittent therapy is possible. The most knowledgeable doctors who have published on intermittent say 12 months at 0.05 or less provides reason for an off therapy period. This off therapy period may be lengthened by using Avodart during the off period. Also other treatments such as vitamin D (50 ng or more by blood test) pomegranate, Leukine injections Thalidomide or Revlimid ($$$$) may also assist in extending the off period. Regular testing for testosterone, Vit D, psa and DHT and others are recommended at regular intervals. Quarterly testing may be longer than preferred for this regimen.
by Johnt on Fri Dec 19, 2008 12:00 AM
You should pick up "Beating Prostate Cancer: Hormonal Therapy and Diet" by Charles Snuffy Myers. Dr Myers does a good job explaining all the hormonal therapies and what is the most effective. A must read for anyone going through hormonal therapy. You can pick it up at Amazon or Rivanna health publications.
by Suziq150 on Tue Aug 25, 2009 12:00 AM
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
If you were considering traveling for cancer treatment, which headline would you find more interesting?
Destination: HOPE. Cancer care that is worth the trip.
Over 84% of our patients travel to our hospital from another state
Neither headline is interesting
We care about your feedback. Let us know how we can improve your CancerCompass experience.